{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:11Z","timestamp":1786985051842,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974440"],"award-info":[{"award-number":["81974440"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930064"],"award-info":[{"award-number":["81930064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874103"],"award-info":[{"award-number":["81874103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bbrc.2021.04.055","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T05:13:53Z","timestamp":1619759633000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["NOL4L, a novel nuclear protein, promotes cell proliferation and metastasis by enhancing the PI3K\/AKT pathway in ovarian cancer"],"prefix":"10.1016","volume":"559","author":[{"given":"Feikai","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoduan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9029-0803","authenticated-orcid":false,"given":"Xipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbrc.2021.04.055_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force","volume":"319","author":"Jt","year":"2018","journal-title":"J.\u00a0Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.bbrc.2021.04.055_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.bbrc.2021.04.055_bib3","first-page":"937","article-title":"Diagnosis and management of ovarian cancer","volume":"93","author":"Ca","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbrc.2021.04.055_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.bbrc.2021.04.055_bib5","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/leu.2010.106","article-title":"CBFA2T2 and C20orf112: two novel fusion partners of RUNX1 in acute myeloid leukemia","volume":"24","author":"Guastadisegni","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2021.04.055_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1387\/ijdb.150307rs","article-title":"Nucleolar protein 4-like has a complex expression pattern in zebrafish embryos","volume":"60","author":"Borah","year":"2016","journal-title":"Int. J. Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbrc.2021.04.055_bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41390-019-0625-z","article-title":"Silencing CASC11 curbs neonatal neuroblastoma progression through modulating microRNA-676-3p\/nucleolar protein 4 like (NOL4L) axis","volume":"87","author":"Yu","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bbrc.2021.04.055_bib8","doi-asserted-by":"crossref","first-page":"146947","DOI":"10.1016\/j.brainres.2020.146947","article-title":"LncRNA double homeobox A pseudogene 8 (DUXAP8) facilitates the progression of neuroblastoma and activates Wnt\/\u03b2-catenin pathway via microRNA-29\/nucleolar protein 4 like (NOL4L) axis","volume":"1746","author":"Nie","year":"2020","journal-title":"Brain Res."},{"issue":"19","key":"10.1016\/j.bbrc.2021.04.055_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194918","article-title":"Conditional knockdown of osteopontin inhibits breast cancer skeletal metastasis","volume":"20","author":"Kovacheva","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"43","key":"10.1016\/j.bbrc.2021.04.055_bib10","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1038\/sj.onc.1208812","article-title":"THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma","volume":"24","author":"Hl","year":"2005","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bbrc.2021.04.055_bib11","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1158\/0008-5472.CAN-18-3842","article-title":"Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1\/ITGB6\/STAT3 signaling Axis in bladder cancer","volume":"79","author":"C","year":"2019","journal-title":"Canc. Res."},{"issue":"8","key":"10.1016\/j.bbrc.2021.04.055_bib12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/onc.2011.291","article-title":"Dominant-negative mechanism of leukemogenic PAX5 fusions","volume":"31","author":"Kawamata","year":"2012","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbrc.2021.04.055_bib13","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1158\/0008-5472.CAN-07-3194","article-title":"Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning","volume":"68","author":"Wang","year":"2008","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.bbrc.2021.04.055_bib14","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.18632\/aging.102817","article-title":"Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer","volume":"12","author":"Chen","year":"2020","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.bbrc.2021.04.055_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbrc.2021.04.055_bib16","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20202683","article-title":"The circadian rhythm and core gene Period2 regulate the chemotherapy effect and multidrug resistance of ovarian cancer through the PI3K signaling pathway","volume":"40","author":"Wang","year":"2020","journal-title":"Biosci. Rep."},{"issue":"19","key":"10.1016\/j.bbrc.2021.04.055_bib17","first-page":"9860","article-title":"MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K\/AKT signaling pathway","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2021.04.055_bib18","first-page":"11897","article-title":"Circadian clock protein PERIOD2 suppresses the PI3K\/akt pathway and promotes cisplatin sensitivity in ovarian cancer","volume":"12","author":"Wang","year":"2020","journal-title":"Canc. Manag. Res."},{"issue":"21","key":"10.1016\/j.bbrc.2021.04.055_bib19","first-page":"10921","article-title":"Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN\/AKT signaling pathway","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2021.04.055_bib20","volume":"vol. 8","author":"Diaz Osterman","year":"2019"},{"issue":"6","key":"10.1016\/j.bbrc.2021.04.055_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060813","article-title":"Hexokinase 2 regulates ovarian cancer cell migration, invasion and stemness via FAK\/ERK1\/2\/MMP9\/NANOG\/SOX9 signaling cascades","volume":"11","author":"Siu","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbrc.2021.04.055_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2020.07.005","article-title":"Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model","volume":"159","author":"Taylan","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2021.04.055_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12967-019-1932-1","article-title":"Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3\u03b2\/\u03b2-catenin signaling pathway","volume":"17","author":"Dai","year":"2019","journal-title":"J.\u00a0Transl. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21006616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21006616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:06:02Z","timestamp":1757765162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21006616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"alternative-id":["S0006291X21006616"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.055","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOL4L, a novel nuclear protein, promotes cell proliferation and metastasis by enhancing the PI3K\/AKT pathway in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}